Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
Identifieur interne : 000186 ( Main/Exploration ); précédent : 000185; suivant : 000187Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
Auteurs : Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine]Source :
- Emerging microbes & infections [ 2222-1751 ] ; 2020.
Descripteurs français
- KwdFr :
- Animaux, Anticoagulants (usage thérapeutique), Anticorps antiviraux (immunologie), Anticorps antiviraux (sang), Coronavirus du syndrome respiratoire du Moyen-Orient (immunologie), Cytokines (immunologie), Cytokines (métabolisme), Facteurs immunologiques (usage thérapeutique), Grippe humaine (immunologie), Humains, Héparine bas poids moléculaire (usage thérapeutique), Immunoglobulines par voie veineuse (usage thérapeutique), Infections à coronavirus (), Infections à coronavirus (immunologie), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (virologie), Lymphocytes B (immunologie), Lymphocytes T (immunologie), Pandémies, Pneumopathie virale (), Pneumopathie virale (immunologie), Pneumopathie virale (traitement médicamenteux), Pneumopathie virale (virologie), Souris, Sous-type H1N1 du virus de la grippe A, Syndrome respiratoire aigu sévère (immunologie), Virus du SRAS (immunologie).
- MESH :
- immunologie : Anticorps antiviraux, Coronavirus du syndrome respiratoire du Moyen-Orient, Cytokines, Grippe humaine, Infections à coronavirus, Lymphocytes B, Lymphocytes T, Pneumopathie virale, Syndrome respiratoire aigu sévère, Virus du SRAS.
- métabolisme : Cytokines.
- sang : Anticorps antiviraux.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : Anticoagulants, Facteurs immunologiques, Héparine bas poids moléculaire, Immunoglobulines par voie veineuse.
- virologie : Infections à coronavirus, Pneumopathie virale.
- Animaux, Humains, Infections à coronavirus, Pandémies, Pneumopathie virale, Souris, Sous-type H1N1 du virus de la grippe A.
English descriptors
- KwdEn :
- Animals, Antibodies, Viral (blood), Antibodies, Viral (immunology), Anticoagulants (therapeutic use), B-Lymphocytes (immunology), Betacoronavirus (pathogenicity), Coronavirus Infections (drug therapy), Coronavirus Infections (immunology), Coronavirus Infections (therapy), Coronavirus Infections (virology), Cytokines (immunology), Cytokines (metabolism), Heparin, Low-Molecular-Weight (therapeutic use), Humans, Immunoglobulins, Intravenous (therapeutic use), Immunologic Factors (therapeutic use), Influenza A Virus, H1N1 Subtype, Influenza, Human (immunology), Mice, Middle East Respiratory Syndrome Coronavirus (immunology), Pandemics, Pneumonia, Viral (drug therapy), Pneumonia, Viral (immunology), Pneumonia, Viral (therapy), Pneumonia, Viral (virology), SARS Virus (immunology), Severe Acute Respiratory Syndrome (immunology), T-Lymphocytes (immunology).
- MESH :
- chemical , blood : Antibodies, Viral.
- chemical , immunology : Antibodies, Viral, Cytokines.
- chemical , metabolism : Cytokines.
- chemical , therapeutic use : Anticoagulants, Heparin, Low-Molecular-Weight, Immunoglobulins, Intravenous, Immunologic Factors.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- immunology : B-Lymphocytes, Coronavirus Infections, Influenza, Human, Middle East Respiratory Syndrome Coronavirus, Pneumonia, Viral, SARS Virus, Severe Acute Respiratory Syndrome, T-Lymphocytes.
- pathogenicity : Betacoronavirus.
- therapy : Coronavirus Infections, Pneumonia, Viral.
- virology : Coronavirus Infections, Pneumonia, Viral.
- Animals, Humans, Influenza A Virus, H1N1 Subtype, Mice, Pandemics.
Abstract
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with droplets and contact as the main means of transmission. Since the first case appeared in Wuhan, China, in December 2019, the outbreak has gradually spread nationwide. Up to now, according to official data released by the Chinese health commission, the number of newly diagnosed patients has been declining, and the epidemic is gradually being controlled. Although most patients have mild symptoms and good prognosis after infection, some patients developed severe and die from multiple organ complications. The pathogenesis of SARS-CoV-2 infection in humans remains unclear. Immune function is a strong defense against invasive pathogens and there is currently no specific antiviral drug against the virus. This article reviews the immunological changes of coronaviruses like SARS, MERS and other viral pneumonia similar to SARS-CoV-2. Combined with the published literature, the potential pathogenesis of COVID-19 is inferred, and the treatment recommendations for giving high-doses intravenous immunoglobulin and low-molecular-weight heparin anticoagulant therapy to severe type patients are proposed.
DOI: 10.1080/22221751.2020.1746199
PubMed: 32196410
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000145
- to stream PubMed, to step Curation: 000145
- to stream PubMed, to step Checkpoint: 000186
- to stream Ncbi, to step Merge: 002627
- to stream Ncbi, to step Curation: 002627
- to stream Ncbi, to step Checkpoint: 002627
- to stream Main, to step Merge: 000189
- to stream Main, to step Curation: 000186
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.</title><author><name sortKey="Lin, Ling" sort="Lin, Ling" uniqKey="Lin L" first="Ling" last="Lin">Ling Lin</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Lu, Lianfeng" sort="Lu, Lianfeng" uniqKey="Lu L" first="Lianfeng" last="Lu">Lianfeng Lu</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Cao, Wei" sort="Cao, Wei" uniqKey="Cao W" first="Wei" last="Cao">Wei Cao</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Li, Taisheng" sort="Li, Taisheng" uniqKey="Li T" first="Taisheng" last="Li">Taisheng Li</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32196410</idno><idno type="pmid">32196410</idno><idno type="doi">10.1080/22221751.2020.1746199</idno><idno type="wicri:Area/PubMed/Corpus">000145</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000145</idno><idno type="wicri:Area/PubMed/Curation">000145</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000145</idno><idno type="wicri:Area/PubMed/Checkpoint">000186</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000186</idno><idno type="wicri:Area/Ncbi/Merge">002627</idno><idno type="wicri:Area/Ncbi/Curation">002627</idno><idno type="wicri:Area/Ncbi/Checkpoint">002627</idno><idno type="wicri:Area/Main/Merge">000189</idno><idno type="wicri:Area/Main/Curation">000186</idno><idno type="wicri:Area/Main/Exploration">000186</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.</title><author><name sortKey="Lin, Ling" sort="Lin, Ling" uniqKey="Lin L" first="Ling" last="Lin">Ling Lin</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Lu, Lianfeng" sort="Lu, Lianfeng" uniqKey="Lu L" first="Lianfeng" last="Lu">Lianfeng Lu</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Cao, Wei" sort="Cao, Wei" uniqKey="Cao W" first="Wei" last="Cao">Wei Cao</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Li, Taisheng" sort="Li, Taisheng" uniqKey="Li T" first="Taisheng" last="Li">Taisheng Li</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author></analytic><series><title level="j">Emerging microbes & infections</title><idno type="eISSN">2222-1751</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antibodies, Viral (blood)</term><term>Antibodies, Viral (immunology)</term><term>Anticoagulants (therapeutic use)</term><term>B-Lymphocytes (immunology)</term><term>Betacoronavirus (pathogenicity)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (immunology)</term><term>Coronavirus Infections (therapy)</term><term>Coronavirus Infections (virology)</term><term>Cytokines (immunology)</term><term>Cytokines (metabolism)</term><term>Heparin, Low-Molecular-Weight (therapeutic use)</term><term>Humans</term><term>Immunoglobulins, Intravenous (therapeutic use)</term><term>Immunologic Factors (therapeutic use)</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza, Human (immunology)</term><term>Mice</term><term>Middle East Respiratory Syndrome Coronavirus (immunology)</term><term>Pandemics</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (immunology)</term><term>Pneumonia, Viral (therapy)</term><term>Pneumonia, Viral (virology)</term><term>SARS Virus (immunology)</term><term>Severe Acute Respiratory Syndrome (immunology)</term><term>T-Lymphocytes (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Anticoagulants (usage thérapeutique)</term><term>Anticorps antiviraux (immunologie)</term><term>Anticorps antiviraux (sang)</term><term>Coronavirus du syndrome respiratoire du Moyen-Orient (immunologie)</term><term>Cytokines (immunologie)</term><term>Cytokines (métabolisme)</term><term>Facteurs immunologiques (usage thérapeutique)</term><term>Grippe humaine (immunologie)</term><term>Humains</term><term>Héparine bas poids moléculaire (usage thérapeutique)</term><term>Immunoglobulines par voie veineuse (usage thérapeutique)</term><term>Infections à coronavirus ()</term><term>Infections à coronavirus (immunologie)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Infections à coronavirus (virologie)</term><term>Lymphocytes B (immunologie)</term><term>Lymphocytes T (immunologie)</term><term>Pandémies</term><term>Pneumopathie virale ()</term><term>Pneumopathie virale (immunologie)</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Pneumopathie virale (virologie)</term><term>Souris</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Syndrome respiratoire aigu sévère (immunologie)</term><term>Virus du SRAS (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term><term>Cytokines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cytokines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticoagulants</term><term>Heparin, Low-Molecular-Weight</term><term>Immunoglobulins, Intravenous</term><term>Immunologic Factors</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term><term>Coronavirus du syndrome respiratoire du Moyen-Orient</term><term>Cytokines</term><term>Grippe humaine</term><term>Infections à coronavirus</term><term>Lymphocytes B</term><term>Lymphocytes T</term><term>Pneumopathie virale</term><term>Syndrome respiratoire aigu sévère</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>B-Lymphocytes</term><term>Coronavirus Infections</term><term>Influenza, Human</term><term>Middle East Respiratory Syndrome Coronavirus</term><term>Pneumonia, Viral</term><term>SARS Virus</term><term>Severe Acute Respiratory Syndrome</term><term>T-Lymphocytes</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Cytokines</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticoagulants</term><term>Facteurs immunologiques</term><term>Héparine bas poids moléculaire</term><term>Immunoglobulines par voie veineuse</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Mice</term><term>Pandemics</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Humains</term><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Souris</term><term>Sous-type H1N1 du virus de la grippe A</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with droplets and contact as the main means of transmission. Since the first case appeared in Wuhan, China, in December 2019, the outbreak has gradually spread nationwide. Up to now, according to official data released by the Chinese health commission, the number of newly diagnosed patients has been declining, and the epidemic is gradually being controlled. Although most patients have mild symptoms and good prognosis after infection, some patients developed severe and die from multiple organ complications. The pathogenesis of SARS-CoV-2 infection in humans remains unclear. Immune function is a strong defense against invasive pathogens and there is currently no specific antiviral drug against the virus. This article reviews the immunological changes of coronaviruses like SARS, MERS and other viral pneumonia similar to SARS-CoV-2. Combined with the published literature, the potential pathogenesis of COVID-19 is inferred, and the treatment recommendations for giving high-doses intravenous immunoglobulin and low-molecular-weight heparin anticoagulant therapy to severe type patients are proposed.</div></front></TEI><affiliations><list><country><li>République populaire de Chine</li></country><settlement><li>Pékin</li></settlement></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Lin, Ling" sort="Lin, Ling" uniqKey="Lin L" first="Ling" last="Lin">Ling Lin</name></noRegion><name sortKey="Cao, Wei" sort="Cao, Wei" uniqKey="Cao W" first="Wei" last="Cao">Wei Cao</name><name sortKey="Li, Taisheng" sort="Li, Taisheng" uniqKey="Li T" first="Taisheng" last="Li">Taisheng Li</name><name sortKey="Lu, Lianfeng" sort="Lu, Lianfeng" uniqKey="Lu L" first="Lianfeng" last="Lu">Lianfeng Lu</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000186 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000186 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32196410
|texte= Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32196410" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |